• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail

Attachment A: List of Presenters at the Hearing

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Previous Section: Decision to Further Delay the Effective Date

FDA Part 15 Hearing -- Prescription Drug Marketing Act 

October 27, 2000

5630 Fishers Lane, Rm 1061
Rockville, MD 20852
8:30 a.m. to 4:30 p.m.


 8:30 Welcome and Introduction of Panelists--Jane Axelrad, Associate Director for Policy, Center for Drug Evaluation and Research (CDER); Diane Maloney, Associate Director for Policy, Center for Biologics Evaluation and Research (CBER)  

Scheduled Presenters 

Susan Winckler, American Pharmaceutical Association
Anthony L. Young, Pharmaceutical Distributors Association
Salvatore Ricciardi, Purity Wholesaler
Patrick C. O'Connor, International Warehouse Logistics Association


Ty Kelley, Food Marketing Institute
Alan Goldhammer, Pharmaceutical Research and Manufacturers of America (PhRMA)
Charles F. Franz, American Veterinary Distributors Association
Larry Sasich, Public Citizen Health Research Group


Shelley Capps, International Academy of Compounding Pharmacists
Paul Devine, Truxton Incorporated (Pharmaceuticals and Medical Supplies)
Chris Lamb, American Red Cross
Jim MacPherson, America's Blood Center
Laura McDonald, Blood Centers of America, Inc./hemerica

Unscheduled Presenters 

Steven Shirley, R&S Sales, Fountain Run, Kentucky
Steve Sims, Lobbyist
Derek Robertson, representing 15 hemophilia treatment centers.

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Next Section: Attachment B: List of Agency Panel Members at the Hearing